ESC Professional Premium Access

State-of-the-art lecture in arrhythmia mechanisms.

Congress Presentation

About the speaker

Professor Ulrich Schotten

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))
4 presentations
0 follower

2 more presentations in this session

Dapagliflozin exhibits class I antiarrhythmic effects which suppress action potential formation in human atrial cardiomyocytes

Speaker: Miss A. Paasche (Heidelberg, DE)


Dapagliflozin but not empagliflozin prevents atrial fibrillation in an experimental whole-heart model

Speaker: Professor G. Frommeyer (Munster, DE)


Access the full session

Insights into arrhythmia mechanisms

Speakers: Professor U. Schotten, Miss A. Paasche, Professor G. Frommeyer

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb